kras mutation and glutathion BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress promotes site-specific metastasis by stimulating glutathione synthesis: Cell Reports Targeting KRAS: from metabolic regulation
Targeting KRAS: from metabolic regulation to cancer treatment Molecular Cancer Springer Nature Link KRAS targeted therapies in cancer: novel approaches and overcoming resistance BMJ Oncology KRAS in Non Small Cell Lung Cancer Encyclopedia MDPI Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv KRAS G12V mutation selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports What should we know about the 'undruggable' target KRAS? MedChemExpress
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





